Ligand-targeted Particulate Nanomedicines Undergoing Clinical Evaluation: Current Status
Roy van der Meel(Eindhoven University of Technology), Ethlinn V.B. van Gaal(Utrecht University), Robbert J. Kok(Utrecht University), Laurens J. C. Vehmeijer(Utrecht University), Gert Storm(Yong In University)
Cited by 19
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k